Methylglyoxal products in pre-symptomatic type 1 diabetes
IntroductionProgression to type 1 diabetes has emerged as a complex process with metabolic alterations proposed to be a significant driver of disease. Monitoring products of altered metabolism is a promising tool for determining the risk of type 1 diabetes progression and to supplement existing pred...
Main Authors: | Sarah C. Shuck, Peter Achenbach, Bart O. Roep, John S. Termini, Carlos Hernandez-Castillo, Christiane Winkler, Andreas Weiss, Anette-Gabriele Ziegler |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2023-01-01
|
Series: | Frontiers in Endocrinology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fendo.2023.1108910/full |
Similar Items
-
Curcumin ameliorates methylglyoxal-induced alterations of cellular morphology and hyperpermeability in human umbilical vein endothelial cells
by: Te-Yu Hu, et al.
Published: (2013-04-01) -
Methylglyoxal-Derived Nucleoside Adducts Drive Vascular Dysfunction in a RAGE-Dependent Manner
by: Seigmund Wai Tsuen Lai, et al.
Published: (2024-01-01) -
Methylglyoxal, the dark side of glycolysis
by: Igor eAllaman, et al.
Published: (2015-02-01) -
Analysis of Methylglyoxal Concentration in a Group of Patients with Newly Diagnosed Prediabetes
by: Edyta Sutkowska, et al.
Published: (2023-11-01) -
RAGE-Dependent Effect of Exogenous Methylglyoxal Intake on Lung Biomechanics in Mice
by: Samiya Al-Robaiy, et al.
Published: (2022-12-01)